Karyn Butler
Psychiatric/Mental Health · Okemos, MINPI 1043763741
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 547 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 27.0% of the total. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 547 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$807
- Neurocrine Biosciences, Inc.$699
- Otsuka America Pharmaceutical, Inc.$649
- Sunovion Pharmaceuticals Inc.$616
- plus $2K from 10 others
What the payments were for
- Food & beverage$7,30397%
- Education$2093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 119 | $2,032 |
| AbbVie | 151 | $1,002 |
| Teva Pharmaceuticals USA, Inc. | 47 | $807 |
| Neurocrine Biosciences, Inc. | 42 | $699 |
| Otsuka America Pharmaceutical, Inc. | 37 | $649 |
| Sunovion Pharmaceuticals Inc. | 65 | $616 |
| Alkermes, Inc. | 20 | $483 |
| Lundbeck LLC | 16 | $275 |
| Johnson & Johnson | 7 | $233 |
| E.r. Squibb & Sons, L.L.C. | 13 | $224 |
| Vanda Pharmaceuticals Inc. | 16 | $203 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Harmony Biosciences LLC | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,512 in reported general payments places this provider in the 95th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 22 | $19,377 |
| RexultiBrexpiprazole | 11 | $14,521 |
| Lurasidone Hcl | 50 | $7,692 |
| Duloxetine Hcl | 130 | $2,919 |
| Aripiprazole | 84 | $2,797 |
| Bupropion XlBupropion Hcl | 82 | $2,719 |
| Trazodone Hcl | 129 | $2,321 |
| Lamotrigine | 145 | $2,011 |
| Paliperidone ErPaliperidone | 18 | $1,895 |
| Buspirone Hcl | 104 | $1,520 |
| Quetiapine Fumarate | 126 | $1,510 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $1,429 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 54 | $920 |
| Olanzapine | 89 | $879 |
| Hydroxyzine Pamoate | 33 | $725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $85 | $19,37722 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $649 | $14,52111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Okemos
- Miriam AdamOkemos$6K
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.